Michael Kauffman

Director, EPIRUS Biopharmaceuticals, Inc.

Companies

Verastem OncologyPresident Jan 8, 2026 to now¹
KYNTRA BIO, INC.Board member Jun 6, 2025 to now²
Kezar Life Sciences, Inc.Board member Jun 20, 2018 to now³
Verastem OncologyBoard member Nov 27, 2012 to now⁴
Adicet Bio, Inc.Board member Nov 18, 2021 to Aug 23, 2024⁵
Karyopharm Therapeutics Inc.Board member Nov 5, 2013 to Mar 2, 2022⁶
Karyopharm Therapeutics Inc.Chief executive officer Nov 13, 2013 to Mar 23, 2021⁷
INFINITY PHARMACEUTICALS, INC.Board member Apr 6, 2017 to Jun 14, 2019⁸
Karyopharm Therapeutics Inc.President Nov 5, 2013 to Nov 13, 2013⁶
Onyx PharmaceuticalsChief Medical Officer Nov 17, 2009 to Feb 11, 2010⁹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

May 11, 2026U 6,369 shares of Kezar Life Sciences, Inc.¹³
Nov 21, 2025Sold 8,550 shares at $10.00 of Verastem Oncology¹¹
May 22, 2025Granted 8,333 shares of Verastem Oncology¹⁴
Jun 18, 2024Granted 8,333 shares of Verastem Oncology¹⁵
Jun 5, 2024Sold 5,900 shares at $1.43 of Adicet Bio, Inc.¹²
Jun 5, 2024Granted 5,900 shares of Adicet Bio, Inc.¹²
Jun 1, 2023Granted 5,900 shares of Adicet Bio, Inc.¹⁶
Feb 28, 2022Sold 6,226 shares at $10.24 of Karyopharm Therapeutics Inc.¹⁰
Feb 28, 2022Sold 6,226 shares at $10.24 of Karyopharm Therapeutics Inc.¹⁰
Feb 28, 2022Granted 21,000 shares of Karyopharm Therapeutics Inc.¹⁰
Feb 17, 2022Sold 9,088 shares at $12.12 of Karyopharm Therapeutics Inc.¹⁷
Feb 17, 2022Sold 9,079 shares at $12.12 of Karyopharm Therapeutics Inc.¹⁷
Feb 7, 2022Sold 6,707 shares at $9.86 of Karyopharm Therapeutics Inc.¹⁸
Feb 7, 2022Sold 6,764 shares at $9.86 of Karyopharm Therapeutics Inc.¹⁸
Jan 3, 2022Sold 5,000 shares at $16.45 of Kezar Life Sciences, Inc.¹⁹
Jan 3, 2022Exercised options 5,000 shares at $5.91 of Kezar Life Sciences, Inc.¹⁹

The numbers on this page point here. Each one links to the record it came from.